(Q39123831)

9 September 2017

title

Histone deacetylases inhibitor trichostatin A increases the expression of Dleu2/miR-15a/16-1 via HDAC3 in non-small cell lung cancer (English)

1 reference

9 September 2017

1 reference

Chi-Qi Chen

1

1 reference

9 September 2017

Cheng-Shui Chen

2

1 reference

9 September 2017

Jun-Jie Chen

3

1 reference

9 September 2017

Lian-Ping Zhou

4

1 reference

9 September 2017

Hong-Lei Xu

5

1 reference

9 September 2017

Wei-Wei Jin

6

1 reference

9 September 2017

Jian-Bo Wu

7

1 reference

9 September 2017

Shen-Meng Gao

8

1 reference

9 September 2017

language of work or name

1 reference

19 July 2013

1 reference

Molecular and Cellular Biochemistry

9 September 2017

published in

1 reference

9 September 2017

volume

383

1 reference

9 September 2017

issue

1-2

1 reference

9 September 2017

page(s)

137-148

1 reference

9 September 2017

cites work

Cancer statistics, 2006

1 reference

https://api.crossref.org/works/10.1007%2FS11010-013-1762-Z

Targeting signaling pathways in lung cancer therapy.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11010-013-1762-Z

21 January 2018

Lung cancer preneoplasia

1 reference

https://api.crossref.org/works/10.1007%2FS11010-013-1762-Z

Histone deacetylase inhibitors in cancer therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11010-013-1762-Z

MicroRNAs: genomics, biogenesis, mechanism, and function

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11010-013-1762-Z

Microarray analysis shows that some microRNAs downregulate large numbers of target mRNAs

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11010-013-1762-Z

MicroRNAs in human cancer: from research to therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11010-013-1762-Z

miR-15 and miR-16 induce apoptosis by targeting BCL2

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11010-013-1762-Z

miR-15b and miR-16 modulate multidrug resistance by targeting BCL2 in human gastric cancer cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11010-013-1762-Z

miR-15a and miR-16 are implicated in cell cycle regulation in a Rb-dependent manner and are frequently deleted or down-regulated in non-small cell lung cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11010-013-1762-Z

miR-34a and miR-15a/16 are co-regulated in non-small cell lung cancer and control cell cycle progression in a synergistic and Rb-dependent manner

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11010-013-1762-Z

Epigenetic therapy of cancer: past, present and future

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11010-013-1762-Z

Antitumor activity of histone deacetylase inhibitors in non-small cell lung cancer cells: development of a molecular predictive model

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11010-013-1762-Z

Aurora A, Aurora B and survivin are novel targets of transcriptional regulation by histone deacetylase inhibitors in non-small cell lung cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11010-013-1762-Z

Synergistic apoptosis induction in leukemic cells by miR-15a/16-1 and arsenic trioxide

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11010-013-1762-Z

DLEU2, frequently deleted in malignancy, functions as a critical host gene of the cell cycle inhibitory microRNAs miR-15a and miR-16-1

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11010-013-1762-Z

MiR-15a and miR-16-1 cluster functions in human leukemia

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11010-013-1762-Z

Regression of murine lung tumors by the let-7 microRNA

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11010-013-1762-Z

Frequent deletions and down-regulation of micro- RNA genes miR15 and miR16 at 13q14 in chronic lymphocytic leukemia

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11010-013-1762-Z

Cancer epigenetics: linking basic biology to clinical medicine.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11010-013-1762-Z

Inhibition of class I histone deacetylases in non-small cell lung cancer by honokiol leads to suppression of cancer cell growth and induction of cell death in vitro and in vivo

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11010-013-1762-Z

Causes and consequences of microRNA dysregulation in cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11010-013-1762-Z

A MicroRNA signature associated with prognosis and progression in chronic lymphocytic leukemia

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11010-013-1762-Z

Induction of apoptosis in small-cell lung cancer cells by an antisense oligodeoxynucleotide targeting the Bcl-2 coding sequence

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11010-013-1762-Z

Bcl-2 and β1-integrin predict survival in a tissue microarray of small cell lung cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11010-013-1762-Z

Bcl-2 small hairpin RNAs enhance radiation-induced apoptosis in A549 cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11010-013-1762-Z

Bcl-2 small interfering RNA sensitizes cisplatin-resistant human lung adenocarcinoma A549/DDP cell to cisplatin and diallyl disulfide

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11010-013-1762-Z

Histone deacetylase inhibition down-regulates cyclin D1 transcription by inhibiting nuclear factor-kappaB/p65 DNA binding

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11010-013-1762-Z

Effectiveness of trichostatin A as a potential candidate for anticancer therapy in non-small-cell lung cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11010-013-1762-Z

The miR-15a-miR-16-1 cluster controls prostate cancer by targeting multiple oncogenic activities

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11010-013-1762-Z

DICER1, DROSHA and miRNAs in patients with non-small cell lung cancer: implications for outcomes and histologic classification.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11010-013-1762-Z

miR-15a and miR-16-1 down-regulation in pituitary adenomas

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11010-013-1762-Z

Prognostic value of miR-16 expression in childhood acute lymphoblastic leukemia relationships to normal and malignant lymphocyte proliferation

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11010-013-1762-Z

Histone deacetylase inhibitors downregulate checkpoint kinase 1 expression to induce cell death in non-small cell lung cancer cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11010-013-1762-Z

Combined proteasome and histone deacetylase inhibition in non-small cell lung cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11010-013-1762-Z

Combinations of DNA Methyltransferase and Histone Deacetylase Inhibitors Induce DNA Damage in Small Cell Lung Cancer Cells: Correlation of Resistance with IFN-Stimulated Gene Expression

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11010-013-1762-Z

Carboplatin and Paclitaxel in combination with either vorinostat or placebo for first-line therapy of advanced non-small-cell lung cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11010-013-1762-Z

Type-specific roles of histone deacetylase (HDAC) overexpression in ovarian carcinoma: HDAC1 enhances cell proliferation and HDAC3 stimulates cell migration with downregulation of E-cadherin

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11010-013-1762-Z

HDAC3 impacts multiple oncogenic pathways in colon cancer cells with effects on Wnt and vitamin D signaling

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11010-013-1762-Z

Strong expression of HDAC3 correlates with a poor prognosis in patients with adenocarcinoma of the lung

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11010-013-1762-Z

HDAC2 overexpression confers oncogenic potential to human lung cancer cells by deregulating expression of apoptosis and cell cycle proteins

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11010-013-1762-Z

Suberoylanilide hydroxamic acid (SAHA) changes microRNA expression profiles in A549 human non-small cell lung cancer cells

21 January 2018

1 reference

12 December 2020

Clinical features of 5,628 primary lung cancer patients: experience at Mayo Clinic from 1997 to 2003

1 reference

12 December 2020

Prognostic implications of miR-16 expression levels in resected non-small-cell lung cancer

1 reference

12 December 2020

The histone deacetylase inhibitor trichostatin A alters microRNA expression profiles in apoptosis-resistant breast cancer cells

1 reference

12 December 2020

MicroRNAs in cancer - from research to therapy

1 reference

12 December 2020

Promises and challenges in developing miRNA as a molecular diagnostic tool for lung cancer

1 reference

12 December 2020

The histone deacetylase inhibitor FR901228 induces caspase-dependent apoptosis via the mitochondrial pathway in small cell lung cancer cells

1 reference

12 December 2020

Induction of apoptosis by trichostatin A, a histone deacetylase inhibitor, is associated with inhibition of cyclooxygenase-2 activity in human non-small cell lung cancer cells

1 reference

12 December 2020

10.1007/S11010-013-1762-Z

Identifiers

DOI

1 reference

9 September 2017

1 reference